The cardiomyopathic hamster (BIO TO2) is a well-established model of heart failure. Deterioration of cardiac function in BIO TO2 is attributed to a defect in δ-sarcoglycan, whereas cardiac dysfunction in δ-sarcoglycan knockout mice is caused by microvascular abnormalities. We examined the relation between cardiac function and the microvasculature, including angiogenic factors, in BIO TO2. Methods and Results: At the age of 5 weeks, percent fractional shortening (%FS) and positive rate of change in left ventricular pressure over time (dP/dt max) were lower in BIO TO2 than in age-matched F1B controls. Capillary density, capillary/myocyte (CM) ratio, capillary domain area (CDA), and myocyte density were similar between BIO TO2 and F1B controls. At the ages of 13 and 20 weeks, BIO had significantly lower capillary and myocyte densities and a significantly higher CM ratio and CDA. Myocyte density positively correlated with %FS and dP/dt max. There were no significant differences in mRNA expression for VEGF, Flt-1, angiopoietin-1, or angiopoietin-2 between BIO TO2 and F1B control. Conclusion: Progressive myocyte loss is responsible for deterioration of cardiac function in BIO TO2. The impaired neovascularization may be involved in the progress of cardiac remodeling in cardiomyopathic hamsters. (Jpn Heart J 2003; 44: 111-126) 
strates delivered via the cardiac circulation. The microcirculation may thus play an important role in the progression of cardiac remodeling.
Angiogenesis, the growth of new vessels, is a complex process involving both the proliferation and migration of endothelial cells (ECs). Angiogenesis occurs only in special circumstances. Myocardial ischemia is an especially potent inducer of angiogenesis in the heart. Various types of cytokines have been shown to induce angiogenesis in experimental models 1) and in vitro assays. 2) Some cytokines, such as basic fibroblast growth factor (bFGF) 3) and vascular endothelial growth factor (VEGF), 4) function through mechanisms involving stimulation of EC growth. VEGF knockout mice have impaired angiogenesis leading to ischemic cardiomyopathy, 5) suggesting that VEGF is a key molecule regulating the balance between cardiac oxygen consumption and vascular growth. Capillary density and VEGF expression are significantly lower in human dilated cardiomyopathy (DCM) than in the nonfailing heart. 6) However, whether capillarization and VEGF expression are altered during progressive cardiac remodeling in the cardiomyopathic hamster remains unknown.
BIO TO2 is an established model of progressive congestive heart failure, caused by an inherited mutation in the gene coding for δ-sarcoglycan, a component of the dystrophin complex. 7) Deficiency of δ-sarcoglycan disrupts the dystrophin-associated glycoprotein complex (DAC), almost completely depletes other sarcoglycans, (α, β, δ) and decreases α-dystroglycan levels. Myocyte loss progresses in the two ways. First, numerous vessel segments with constrictions and focal luminal narrowing develop. These vessel irregularities lead to focal ischemic injury and necrosis, resulting in myocyte loss. 8) Second, myocyte loss progresses owing to Ca 2+ overload caused by high basal activity of Ca 2+ permeable channels or mechanosensitive Ca 2+ permeable channels, resulting from the disruption of DAC. 9) Cardiac remodeling progresses after myocyte loss. Capillary density is often used as an index of angiogenesis and microcirculation. However, capillary density depends on myocyte area and provides no information on capillary proliferation. The capillary to myocyte ratio (CM ratio, the number of capillaries divided by the number of myocytes in a unit area) is a better index of capillarization. Capillary domain area (CDA, the area to which one capillary could provide oxygen) is considered to be a good index of the diffusion distance of oxygen.
We hypothesized that impaired angiogenesis is responsible for insufficient blood to meet the demands of the remodeled myocardium in heart failure. To test this hypothesis, we examined the relation between cardiac function and structure,including fibrosis, myocytes, and blood vessels, and investigated whether changes in the microcirculation affect cardiac remodeling. 
METHODS
Experimental protocol: Experiments were carried out in male, cardiomyopathic hamsters (BIO TO2) aged 5, 13, and 20 weeks (BIO Breeders, Fitchburg, Massachusetts). F1B hamsters were used as controls, and each group consisted of 10 animals. The left ventricle from each hamster underwent histological and biochemical analyses after echocardiography and catheterization.
The protocol conformed with the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1985) . Echocardiography: Echocardiography was done as described previously. 10) Briefly, at the age of 5, 13, and 20 weeks, each hamster was anesthetized with an intraperitoneal injection of urethane (50 mg/100 g of body weight) and α-chloralose (100 mg/100 g of body weight). Transthoracic echocardiograms were obtained with a 13-MHz linear scanner (Hitachi EUB 8000). M-mode echocardiograms were recorded, and the left ventricular end-diastolic dimension (LVDd) and percent fractional shortening (%FS) were determined. Catheterization: The catheterization method was described previously.
11) A 1.4-French micro-tip catheter manometer (SPR-677, Millar Instruments, Inc., Houston, USA) with a TC-510 control unit (Millar Instruments) was inserted into the left ventricle. As indices of hemodynamics, the maximum rate of rise in left ventricular pressure (LV dP/dT max) and the maximum rate of fall in left ventricular pressure (LV dP/dT min) were derived from the left ventricular pressure by analysis with a computer system (MP-100WS, BIOPAC System, Inc., Santa Barbara CA, USA) and the AcqKnowledge 2.0 program for Macintosh (BIOPAC System). Histological examination: Previous studies have shown that histochemical staining with the lectin Griffonia simplicifolia (GSA-B4) is a sensitive and reliable method with which to visualize the entire capillary vasculature within the skeletal and cardiac muscles of the hamster. 12) Therefore, left ventricular sections were stained with GSA-B4 (Sigma Chemical Co., St. Louis, MO) to examine the structure of the capillary bed. Hearts were removed, dipped into OCT. compound (Tissue-TekTM, Sakura Finetechnical Co., Inc., Tokyo), frozen in liquid nitrogen, and stored at -80°C until use. Sections 8 µm thick were obtained from cross-sections taken at the widest part of the left ventricle by means of a cryostat, fixed in acetone for 10 minutes, air-dried, and then placed in phosphate-buffered saline (PBS) twice for 15 minutes each time. The sections were treated with 3% hydrogen peroxide in methanol for 15 minutes at 4°C to inhibit intrinsic peroxidase activity, and washed twice for 5 minutes each in PBS.
GSA-B4 was diluted 1:100 in PBS and incubated with the tissue sections overnight at 4°C. The slides were then reacted with streptoavidin conjugated to peroxidase (Nichirei, Co., Ltd., Tokyo) for 8 minutes and thoroughly rinsed twice in PBS for 5 minutes each time. Sites of bound lectin were visualized by incubation in a 3', 3'-diaminobenzidine (DAB)-hydrogen peroxide substrate medium (Nichirei) for 5 minutes, followed by two additional rinses. To enhance the DAB reaction, the sections were rinsed with 0.05 M sodium bicarbonate (pH 9.6) for 10 minutes and then incubated in DAB Enhancing Solution (Vector Laboratories, Inc. Burlingame, USA) for 15 seconds. After counterstaining with hematoxylin, the tissue sections were dehydrated through a graded series of ethanol and xylene, placed on slides, and cover slipped. Pictures of the sections were taken randomly in the subepicardial region, midventricular region, and subendocardial region using a light microscope (PM-10AK, Olympus Co., Ltd., Japan) and a camera (C-35AD, Olympus). The numbers of coronary capillaries and cardiomyocyte nuclei were counted in an 11.25 mm 2 area per section. We calculated myocyte density, capillary density, the CM ratio, and capillary domain area (CDA) as described previously.
13)
Northern blot analysis: The cDNA probes used in the present study were cDNA for rat VEGF, angiopoietin-1, angiopoietin-2, flt-1, TGF-β, collagen I, and a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA as an internal control. All cDNA probes were uniformly labeled with random primers using Klenow enzyme (Boehringer Mannheim) and a-[32P] dCTP (Life Science Products). Each preparation of total RNA was isolated from a left ventricular tissue sample using TRIzol reagent (GIBCO BRL). Twenty micrograms of denatured RNA was size fractioned on 2% formaldehyde 1.2-1.5% agarose gels and then transferred to a nylon membrane (Hybond-N 1, Amersham Life Science) and incubated overnight in 20 X saline sodium citrate transfer buffer. Northern blot analysis was carried out according to conventional methods. Each membrane was exposed at -80°C to x-ray films (x-OMAT, Eastman Kodak) with a single intensifying screen to increase exposure times and obtain signals in the linear range for densitometric analysis of each mRNA species. The GAPDH mRNA diffuse density score, used as an internal control, has been shown to be unchanged in the BIO TO2 heart. To evaluate mRNA levels, an optical scanner (GT-9500, Seiko, Tokyo) was utilized to digitize the autoradiograms. The density of the autoradiogram bands in the digitized image was measured with an NIH Image program. Angiography: To visualize small intramyocardial coronary arteries, we performed angiography using synchrotron radiation (SR) at the Japan Synchrotron Radiation Research Institute (SPring-8, Hyogo, Japan). To prepare samples for visualization, we injected contrast medium developed by Fujimoto, et al 14) into a Langendorff heart preparation of the BIO TO2 at a physiological pressure. The heart was chilled rapidly to 0°C and was fixed in paraformaldehyde for 24 hours at 4°C. The heart was then cut cylindrically to a diameter of 3 mm. We took pho- tographs of the cylindrical samples using SR at SPring 8. The energy of SR was 17 KeV, and the exposure time was 30 seconds. The sample was rotated 180 degrees in increments of 0.5 degrees to acquire three-dimensional information. These data were stored on 16 bits. Computed tomographic (CT) images were obtained after these data were reconstructed using an original program provided by Dr. N. Yagi. The blood vessel to myocardium ratio (BM ratio) was calculated from CT images using public domain NIH Image programs and a computer (Power Macintosh G4, Apple Computer). Statistical analysis: All values are expressed as the mean±SEM. Analysis of variance with subsequent Fisher`s test was used to determine the significance of differences in multiple comparisons. Values of P<0.05 were considered to indicate statistical significance.
RESULTS

Pathological changes:
The results of morphometric analysis are shown in Figures 1 and 2 while a photograph of pathological changes is shown in Figure 3 . Changes in density and breadth of cardiomyocytes: Hearts obtained from 13-and 20-week-old BIO TO2 hamsters were substantially dilated compared with those obtained from normal F1B controls of similar age. Cardiomyocyte density was Figure 4 . Percent fractional shortening (%FS) was already lower in the Table  and Figure 5 . There were no significant differences in heart rate. BIO TO2 hamsters had significantly lower peak left ventricular pressure (LVP) and higher left ventricular end-diastolic pressure (LVEDP) than F1B controls. The dP/dt max, which is highly sensitive to changes in contractility, was significantly lower in BIO TO2 hamsters than in F1B controls at 5, 13, and 20 weeks (10634.4±1121.23 mmHg/sec vs 8708.0±545.91 mmHg/sec at 5 weeks, P<0.05; 11156.2±1316.39 mmHg/sec vs 7316.2±980.11 mmHg/sec at 13 weeks, P<0.05; 11289.0±895.57 mmHg/sec vs 5824.0±488.44 mmHg/sec at 20 weeks, P<0.01). Furthermore, the dP/dt max worsened progressively with age. There were no significant differences in the dP/dt min, which is highly sensitive to changes in diastolic function, between BIO TO2 hamsters and F1B controls at 5 weeks (7408.8±599.96 mmHg/ sec vs 7130.8±689.25 mmHg/sec); however, 13-and 20-week-old BIO TO2 hamsters had significantly lower dP/dT min than the age-matched F1B controls (7210.4±809.75 mmHg/sec vs 5345.2±743.27 mmHg/sec at 13 weeks, P<0.001; 6873.0±452.62 mmHg/sec vs 3966.6±131.99 mmHg/sec at 20 weeks, P<0.001). mRNA expression: Representative autoradiographs obtained by Northern blot analysis are shown in Figure 6 . There were no significant differences in the levels of mRNA expression for angiogenesis-related genes (VEGF, angiopoietin 1, angiopoietin 2, and Flk-1) between the BIO TO2 hamsters and F1B controls at 20 weeks. There were no significant differences in the levels of mRNA expression for VEGF for any period. The levels of mRNA expression of TGF-β and collagen I were significantly higher in the BIO TO2 hamsters than in F1B controls at 5, 13, and 20 weeks.
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Angiography: Representative angiograms are shown in Figure 7 . Microvasculature density was less in the BIO TO2 hamsters than in F1B controls. The BM ratio in the BIO TO2 hamsters was significantly lower than that in F1B controls (10.7±1.96% vs 5.08±1.28%, P<0.05). 
DISCUSSION
Our study has demonstrated that cardiac remodeling progressed with age in BIO TO2 hamsters and led to progressive deterioration of cardiac function. This process may be accelerated by impaired neovascularization.
The etiology and pathogenesis of DCM remain unclear. In BIO TO2 hamsters, an established model of DCM, disease processes have diverse effects on myocardial tissue, as evidenced by focal cell loss, microvascular spasms, 15) inhomogeneous capillary flow 16) and resultant focal ischemic areas, marked heterogeneity in cellular calcium content 17) due to enhanced phospholipid metabolism, 18) and increased sarcoplasmic membrane permeability. 19) Recently, a defect in the gene for sarcoglycan, a dystrophin-associated glycoprotein, was reported in BIO TO2. 7) Beginning at approximately 30 days of age, progressive myocytolytic necrosis develops in heart and skeletal muscle and myocyte integrity is lost through the slow loss of myofibrils, which are replaced by amorphous material. We used BIO TO2 hamsters as a model of progressive congestive heart failure to determine whether neovascularization affects cardiac remodeling, a process characteristic of the end stage of various types of heart disease, including old myocardial infarction, myocarditis, and dilated cardiomyopathy. Replacement fibrosis and myocyte hypertrophy may participate in cardiac remodeling after progressive myocyte loss. These factors might be closely related to increased CDA and a decreased CM ratio. Capillarization of BIO TO2 hamsters was thus impaired. Because one capillary supplies a large area, myocytes could have an inadequate oxygen supply. The angiogenic factors VEGF, angiopoietin-1, angiopoietin-2, and flt-1 have been shown to be induced in the heart by hypoxia and ischemia in vivo 20) and contribute to ischemia-mediated angiogenesis. However, we found that not all angiogenic factors were expressed at adequate levels despite the insufficient oxygen supply. These observations support the hypothesis that angiogenesis is impaired in BIO TO2 hamsters. This impaired angiogenesis most likely induced cardiac remodeling, which in turn led to progressive ventricular dilatation and a worsening of heart failure.
A substantial increase in fibrillar collagen deposition, which leads to increased interstitial and perivascular fibrosis, has been observed in the cardiac ventricles of BIO TO2. Several experimental studies provide evidence that myocardial fibrosis can be mediated via specific growth factors (e.g., TGF-β1, platelet-derived growth factor, insulin-like growth factor, and basic fibroblast growth factors). 21) We focused on TGF-β1 expression in BIO TO2 because TGF-β1, in particular, is closely linked to cardiomyocyte hypertrophy 22) and excessive production of extracellular matrix. 23) We demonstrated that increased expression of collagen I mRNA was apparent at 13 weeks of age, and that TGF-β1 was consistently expressed at high levels in BIO TO2, suggesting that TGF-β1 has an important role in the progression of cardiac remodeling.
Microvascular angiography was performed with synchrotron radiation at Spring-8, which is the largest and brightest third-generation facility in the world. 24) Because the synchrotron radiation at Spring-8 is ultrabright and highly directional, we could visualize details of the microvasculature that are not discernible by conventional x-ray examination. Microvascular impairment in heart failure was confirmed both pathologically and angiographically. Conclusion: Progressive myocyte loss is responsible for deterioration of cardiac function in BIO TO2. The impaired neovascularization may be involved in the progress of cardiac remodeling in cardiomyopathic hamsters. 
